MedTrace Logo

Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)

NCT01477528 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 201

Last updated 2022-06-24

No results posted yet for this study

Summary

The purpose of this observational study is to obtain multi-center data on HeartMate II (HMII) patients managed with reduced anticoagulation or anti-platelet regimes, and the incidence of thrombotic and bleeding adverse events associated with these regimes.

Conditions

  • Anticoagulation
  • Left Ventricular Assist Device

Sponsors & Collaborators

  • Thoratec Europe Ltd

    collaborator INDUSTRY

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Pooja Chatterjee · Thoratec Europe Limited

  • David Farrar, PhD · Thoratec Corporation

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2015-07-31
Completion
2015-08-31

Countries

  • United States
  • Austria
  • Czechia
  • France
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01477528 on ClinicalTrials.gov